市場調査レポート
商品コード
1104919

CAR-T細胞療法の世界市場 - 考察・予測 (2028年まで)

Global CAR T-Cell Therapy Market Insights, Forecast to 2028

出版日: | 発行: QYResearch | ページ情報: 英文 120 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=154.46円
CAR-T細胞療法の世界市場 - 考察・予測 (2028年まで)
出版日: 2022年07月21日
発行: QYResearch
ページ情報: 英文 120 Pages
納期: 2~3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

COVID-19のパンデミックにより、世界のCAR-T細胞療法の市場規模は、2022年に28億583万米ドルと推定され、2028年までに135億304万米ドルに再調整され、予測期間(2022年~2028年)にCAGRで29.94%の成長が予測されています。

世界のCAR-T細胞療法の主要メーカーは、Novartis、Gilead Sciences、Bristol-Myers Squibb、J & J、JW Therapeutics、FOSUNKiteなどです。収益面では、2021年のCAR-T細胞療法の市場シェアは、世界3大企業が99.32%を占めています。

目次

第1章 レポートの概要

  • 調査範囲
  • 市場分析:タイプ別
    • 世界のCAR-T細胞療法の市場規模の成長率:タイプ別(2017年、2021年、2028年)
    • CD19標的
    • BCMA標的
  • 市場:用途別
    • 世界のCAR-T細胞療法の市場規模の成長率:用途別(2017年、2021年、2028年)
    • リンパ腫
    • 多発性骨髄腫
  • 調査目的
  • 考慮年

第2章 世界の成長動向

  • 世界のCAR-T細胞療法市場の見通し(2017年~2028年)
  • CAR-T細胞療法の成長動向:地域別
  • CAR-T細胞療法の市場力学
    • CAR-T細胞療法の業界動向
    • CAR-T細胞療法の市場促進要因
    • CAR-T細胞療法の市場課題
    • CAR-T細胞療法の市場抑制要因
    • 世界・中国のCAR-T細胞療法市場に対する参入障壁分析
  • 市場エコシステムとバリューチェーン分析

第3章 競合情勢:主要企業別

  • 世界のCAR-T細胞療法の主要企業:収益別
  • 世界のCAR-T細胞療法の市場シェア:企業タイプ別(ティア1、ティア2、ティア3)
  • 対象企業 - ランキング:CAR-T細胞療法の収益別
  • 世界のCAR-T細胞療法の市場集中度
  • CAR-T細胞療法の主要企業の本社と提供エリア
  • CAR-T細胞療法の主要企業の製品ソリューションとサービス
  • CAR-T細胞療法の市場参入日
  • M&A、拡張計画

第4章 CAR-T細胞療法の内訳データ:タイプ別

  • 世界のCAR-T細胞療法の過去の市場規模:タイプ別(2017年~2022年)
  • 世界のCAR-T細胞療法の市場規模予測:タイプ別(2023年~2028年)

第5章 CAR-T細胞療法の内訳データ:用途別

  • 世界のCAR-T細胞療法の過去の市場規模:用途別(2017年~2022年)
  • 世界のCAR-T細胞療法の市場規模予測:用途別(2023年~2028年)

第6章 北米

  • 北米のCAR-T細胞療法の市場規模(2017年~2028年)
  • 北米のCAR-T細胞療法の市場規模:タイプ別
  • 北米のCAR-T細胞療法の市場規模:用途別
  • 北米のCAR-T細胞療法の市場規模:国別
    • 米国
    • カナダ
    • メキシコ

第7章 欧州

  • 欧州のCAR-T細胞療法の市場規模(2017年~2028年)
  • 欧州のCAR-T細胞療法の市場規模:タイプ別
  • 欧州のCAR-T細胞療法の市場規模:用途別
  • 欧州のCAR-T細胞療法の市場規模:国別
    • ドイツ
    • フランス
    • 英国
    • イタリア

第8章 アジア太平洋地域

  • アジア太平洋地域のCAR-T細胞療法の市場規模(2017年~2028年)
  • アジア太平洋地域のCAR-T細胞療法の市場規模:タイプ別
  • アジア太平洋地域のCAR-T細胞療法の市場規模:用途別
  • アジア太平洋地域のCAR-T細胞療法の市場規模:地域別
    • 中国
    • 日本
    • 韓国
    • インド

第9章 南米

  • 南米のCAR-T細胞療法の市場規模(2017年~2028年)
  • 南米のCAR-T細胞療法の市場規模:タイプ別
  • 南米のCAR-T細胞療法の市場規模:用途別
  • 南米のCAR-T細胞療法の市場規模:国別
    • ブラジル

第10章 中東・アフリカ

  • 中東・アフリカのCAR-T細胞療法の市場規模(2017年~2028年)
  • 中東・アフリカのCAR-T細胞療法の市場規模:タイプ別
  • 中東・アフリカのCAR-T細胞療法の市場規模:用途別
  • 中東・アフリカのCAR-T細胞療法の市場規模:国別
    • 中東
    • アフリカ

第11章 主要企業プロファイル

  • Novartis
  • Gilead Sciences
  • Bristol-Myers Squibb
  • J & J
  • JW Therapeutics
  • FOSUNKite
  • CARsgen Therapeutics (Pipeline)
  • Autolus Therapeutics (Pipeline)
  • Sorrento Therapeutics (Pipeline)
  • Mustang Bio (Pipeline)
  • Bluebird Bio (Pipeline)
  • Cellectis (Pipeline)
  • Allogene Therapeutics (Pipeline)
  • Celyad (Pipeline)

第12章 アナリストの視点/結論

第13章 付録

図表

LIST OF TABLES

  • Table 1. Global CAR T-Cell Therapy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
  • Table 2. Key Players of CD19-targeted
  • Table 3. Key Players of BCMA-targeted
  • Table 4. Global CAR T-Cell Therapy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
  • Table 5. Global CAR T-Cell Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
  • Table 6. Global CAR T-Cell Therapy Market Size by Region (2017-2022) & (US$ Million)
  • Table 7. Global CAR T-Cell Therapy Market Share by Region (2017-2022)
  • Table 8. Global CAR T-Cell Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
  • Table 9. Global CAR T-Cell Therapy Market Share by Region (2023-2028)
  • Table 10. CAR T-Cell Therapy Market Trends
  • Table 11. CAR T-Cell Therapy Market Drivers
  • Table 12. CAR T-Cell Therapy Market Challenges
  • Table 13. CAR T-Cell Therapy Market Restraints
  • Table 14. Entry Barrier CAR T-Cell Therapy on Global Market and China Market
  • Table 15. Global CAR T-Cell Therapy Revenue by Players (2017-2022) & (US$ Million)
  • Table 16. Global CAR T-Cell Therapy Market Share by Players (2017-2022)
  • Table 17. Global Top CAR T-Cell Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CAR T-Cell Therapy as of 2021)
  • Table 18. Ranking of Global Top CAR T-Cell Therapy Companies by Revenue (US$ Million) in 2021
  • Table 19. Global 5 Largest Players Market Share by CAR T-Cell Therapy Revenue (CR5 and HHI) & (2017-2022)
  • Table 20. Key Players Headquarters and Area Served
  • Table 21. Key Players CAR T-Cell Therapy Product Solution and Service
  • Table 22. Date of Enter into CAR T-Cell Therapy Market
  • Table 23. Mergers & Acquisitions, Expansion Plans
  • Table 24. Global CAR T-Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
  • Table 25. Global CAR T-Cell Therapy Revenue Market Share by Type (2017-2022)
  • Table 26. Global CAR T-Cell Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
  • Table 27. Global CAR T-Cell Therapy Revenue Market Share by Type (2023-2028)
  • Table 28. Global CAR T-Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
  • Table 29. Global CAR T-Cell Therapy Revenue Market Share by Application (2017-2022)
  • Table 30. Global CAR T-Cell Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
  • Table 31. Global CAR T-Cell Therapy Revenue Market Share by Application (2023-2028)
  • Table 32. North America CAR T-Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
  • Table 33. North America CAR T-Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
  • Table 34. North America CAR T-Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
  • Table 35. North America CAR T-Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
  • Table 36. North America CAR T-Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
  • Table 37. North America CAR T-Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
  • Table 38. Europe CAR T-Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
  • Table 39. Europe CAR T-Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
  • Table 40. Europe CAR T-Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
  • Table 41. Europe CAR T-Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
  • Table 42. Europe CAR T-Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
  • Table 43. Europe CAR T-Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
  • Table 44. Asia-Pacific CAR T-Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
  • Table 45. Asia-Pacific CAR T-Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
  • Table 46. Asia-Pacific CAR T-Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
  • Table 47. Asia-Pacific CAR T-Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
  • Table 48. Asia-Pacific CAR T-Cell Therapy Market Size by Region (2017-2022) & (US$ Million)
  • Table 49. Asia-Pacific CAR T-Cell Therapy Market Size by Region (2023-2028) & (US$ Million)
  • Table 50. South America CAR T-Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
  • Table 51. South America CAR T-Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
  • Table 52. South America CAR T-Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
  • Table 53. South America CAR T-Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
  • Table 54. South America CAR T-Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
  • Table 55. South America CAR T-Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
  • Table 56. Middle East & Africa CAR T-Cell Therapy Market Size by Type (2017-2022) & (US$ Million)
  • Table 57. Middle East & Africa CAR T-Cell Therapy Market Size by Type (2023-2028) & (US$ Million)
  • Table 58. Middle East & Africa CAR T-Cell Therapy Market Size by Application (2017-2022) & (US$ Million)
  • Table 59. Middle East & Africa CAR T-Cell Therapy Market Size by Application (2023-2028) & (US$ Million)
  • Table 60. Middle East & Africa CAR T-Cell Therapy Market Size by Country (2017-2022) & (US$ Million)
  • Table 61. Middle East & Africa CAR T-Cell Therapy Market Size by Country (2023-2028) & (US$ Million)
  • Table 62. Novartis Company Details
  • Table 63. Novartis Business Overview
  • Table 64. Novartis CAR T-Cell Therapy Product
  • Table 65. Novartis Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
  • Table 66. Novartis Recent Development
  • Table 67. Gilead Sciences Company Details
  • Table 68. Gilead Sciences Business Overview
  • Table 69. Gilead Sciences CAR T-Cell Therapy Product
  • Table 70. Gilead Sciences Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
  • Table 71. Gilead Sciences Recent Development
  • Table 72. Bristol-Myers Squibb Company Details
  • Table 73. Bristol-Myers Squibb Business Overview
  • Table 74. Bristol-Myers Squibb CAR T-Cell Therapy Product
  • Table 75. Bristol-Myers Squibb Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
  • Table 76. Bristol-Myers Squibb Recent Development
  • Table 77. J & J Company Details
  • Table 78. J & J Business Overview
  • Table 79. J & J CAR T-Cell Therapy Product
  • Table 80. J & J Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
  • Table 81. J & J Recent Development
  • Table 82. JW Therapeutics Company Details
  • Table 83. JW Therapeutics Business Overview
  • Table 84. JW Therapeutics CAR T-Cell Therapy Product
  • Table 85. JW Therapeutics Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
  • Table 86. JW Therapeutics Recent Development
  • Table 87. FOSUNKite Company Details
  • Table 88. FOSUNKite Business Overview
  • Table 89. FOSUNKite CAR T-Cell Therapy Product
  • Table 90. FOSUNKite Revenue in CAR T-Cell Therapy Business (2017-2022) & (US$ Million)
  • Table 91. FOSUNKite Recent Development
  • Table 92. CARsgen Therapeutics Company Details
  • Table 93. CARsgen Therapeutics Business Overview
  • Table 94. CARsgen Therapeutics CAR T-Cell Therapy Product
  • Table 95. Autolus Therapeutics Company Details
  • Table 96. Autolus Therapeutics Business Overview
  • Table 97. Autolus Therapeutics CAR T-Cell Therapy Product
  • Table 98. Sorrento Therapeutics Company Details
  • Table 99. Sorrento Therapeutics Business Overview
  • Table 100. Sorrento Therapeutics CAR T-Cell Therapy Product
  • Table 101. Mustang Bio Company Details
  • Table 102. Mustang Bio Business Overview
  • Table 103. Bluebird Bio Company Details
  • Table 104. Bluebird Bio Business Overview
  • Table 105. Bluebird Bio CAR T-Cell Therapy Product
  • Table 106. Bluebird Bio Recent Development
  • Table 107. Cellectis Company Details
  • Table 108. Cellectis Business Overview
  • Table 109. Cellectis CAR T-Cell Therapy Product
  • Table 110. Allogene Therapeutics Company Details
  • Table 111. Allogene Therapeutics Business Overview
  • Table 112. Allogene Therapeutics CAR T-Cell Therapy Product
  • Table 113. Celyad Company Details
  • Table 114. Celyad Business Overview
  • Table 115. Celyad CAR T-Cell Therapy Product
  • Table 116. Research Programs/Design for This Report
  • Table 117. Key Data Information from Secondary Sources
  • Table 118. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global CAR T-Cell Therapy Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
  • Figure 2. Global CAR T-Cell Therapy Market Share by Type: 2021 VS 2028
  • Figure 3. CD19-targeted Features
  • Figure 4. BCMA-targeted Features
  • Figure 5. Global CAR T-Cell Therapy Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
  • Figure 6. Global CAR T-Cell Therapy Market Share by Application: 2021 VS 2028
  • Figure 7. Lymphoma Case Studies
  • Figure 8. Multiple Myeloma Case Studies
  • Figure 9. CAR T-Cell Therapy Report Years Considered
  • Figure 10. Global CAR T-Cell Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
  • Figure 11. Global CAR T-Cell Therapy Market Size, (US$ Million), 2017 VS 2022 VS 2028
  • Figure 12. Global CAR T-Cell Therapy Market Share by Region: 2021 VS 2028
  • Figure 13. The Drug Development Process
  • Figure 14. Global CAR T-Cell Therapy Market Share by Players in 2021
  • Figure 15. The Top 5 Players Market Share by CAR T-Cell Therapy Revenue in 2021
  • Figure 16. North America CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 17. North America CAR T-Cell Therapy Market Share by Type (2017-2028)
  • Figure 18. North America CAR T-Cell Therapy Market Share by Application (2017-2028)
  • Figure 19. North America CAR T-Cell Therapy Market Share by Country (2017-2028)
  • Figure 20. United States CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 21. Canada CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 22. Mexico CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 23. Europe CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 24. Europe CAR T-Cell Therapy Market Share by Type (2017-2028)
  • Figure 25. Europe CAR T-Cell Therapy Market Share by Application (2017-2028)
  • Figure 26. Europe CAR T-Cell Therapy Market Share by Country (2017-2028)
  • Figure 27. Germany CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 28. France CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 29. U.K. CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 30. Italy CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 31. Asia-Pacific CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 32. Asia-Pacific CAR T-Cell Therapy Market Share by Type (2019-2028)
  • Figure 33. Asia-Pacific CAR T-Cell Therapy Market Share by Application (2019-2028)
  • Figure 34. Asia-Pacific CAR T-Cell Therapy Market Share by Region (2019-2028)
  • Figure 35. China CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 36. Japan CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 37. South Korea CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 38. India CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 39. South America CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 40. South America CAR T-Cell Therapy Market Share by Type (2022-2028)
  • Figure 41. South America CAR T-Cell Therapy Market Share by Application (2022-2028)
  • Figure 42. South America CAR T-Cell Therapy Market Share by Country (2022-2028)
  • Figure 43. Brazil CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 44. Middle East & Africa CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 45. Middle East & Africa CAR T-Cell Therapy Market Share by Type (2025-2028)
  • Figure 46. Middle East & Africa CAR T-Cell Therapy Market Share by Application (2025-2028)
  • Figure 47. Middle East & Africa CAR T-Cell Therapy Market Share by Country (2025-2028)
  • Figure 48. Middle East CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 49. Africa CAR T-Cell Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
  • Figure 50. Novartis Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
  • Figure 51. Gilead Sciences Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
  • Figure 52. Bristol-Myers Squibb Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
  • Figure 53. J & J Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
  • Figure 54. JW Therapeutics Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
  • Figure 55. FOSUNKite Revenue Growth Rate in CAR T-Cell Therapy Business (2017-2022)
  • Figure 56. Mustang Bio CAR T-Cell Therapy Product
  • Figure 57. Bottom-up and Top-down Approaches for This Report
  • Figure 58. Data Triangulation
  • Figure 59. Key Executives Interviewed 102
目次

Market Analysis and Insights:

Due to the COVID-19 pandemic, the global CAR T-Cell Therapy market size is estimated to be worth US$ 2805.83 million in 2022 and is forecast to a readjusted size of US$ 13503.04 million by 2028 with a CAGR of 29.94% during the forecast period 2022-2028.

The global major manufacturers of CAR T-Cell Therapy include Novartis, Gilead Sciences, Bristol-Myers Squibb, J & J, JW Therapeutics, FOSUNKite, etc. In terms of revenue, the global three largest players hold a 99.32% market share of CAR T-Cell Therapy in 2021.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global CAR T-Cell Therapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global CAR T-Cell Therapy market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global CAR T-Cell Therapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global CAR T-Cell Therapy market.

Scope and Market Size:

CAR T-Cell Therapy market is segmented by players, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global CAR T-Cell Therapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2017-2028.

By Company

  • Novartis
  • Gilead Sciences
  • Bristol-Myers Squibb
  • J & J
  • JW Therapeutics
  • FOSUNKite
  • CARsgen Therapeutics (Pipeline)
  • Autolus Therapeutics(Pipeline)
  • Sorrento Therapeutics(Pipeline)
  • Mustang Bio(Pipeline)
  • Bluebird Bio(Pipeline)
  • Cellectis(Pipeline)
  • Allogene Therapeutics(Pipeline)
  • Celyad(Pipeline)

Segment by Type

  • CD19-targeted
  • BCMA-targeted

Segment by Application

  • Lymphoma
  • Multiple Myeloma

By Region

  • North America
    • United States
    • Canada
    • Mexico
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Rest of Asia
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Rest of Europe
  • South America
    • Brazil
    • Rest of South America
  • Middle East & Africa
    • Middle East
    • Africa

TABLE OF CONTENTS

1 REPORT OVERVIEW

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global CAR T-Cell Therapy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
    • 1.2.2 CD19-targeted
    • 1.2.3 BCMA-targeted
  • 1.3 Market by Application
    • 1.3.1 Global CAR T-Cell Therapy Market Share by Application: 2017 VS 2021 VS 2028
    • 1.3.2 Lymphoma
    • 1.3.3 Multiple Myeloma
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 GLOBAL GROWTH TRENDS

  • 2.1 Global CAR T-Cell Therapy Market Perspective (2017-2028)
  • 2.2 CAR T-Cell Therapy Growth Trends by Region
    • 2.2.1 CAR T-Cell Therapy Market Size by Region: 2017 VS 2021 VS 2028
    • 2.2.2 CAR T-Cell Therapy Historic Market Size by Region (2017-2022)
    • 2.2.3 CAR T-Cell Therapy Forecasted Market Size by Region (2023-2028)
  • 2.3 CAR T-Cell Therapy Market Dynamics
    • 2.3.1 CAR T-Cell Therapy Industry Trends
    • 2.3.2 CAR T-Cell Therapy Market Drivers
    • 2.3.3 CAR T-Cell Therapy Market Challenges
    • 2.3.4 CAR T-Cell Therapy Market Restraints
    • 2.3.5 Analysis of Entry Barrier CAR T-Cell Therapy on Global Market and China Market
  • 2.4 Market Ecosystem and Value Chain Analysis

3 COMPETITION LANDSCAPE BY KEY PLAYERS

  • 3.1 Global Top CAR T-Cell Therapy Players by Revenue
    • 3.1.1 Global Top CAR T-Cell Therapy Players by Revenue (2017-2022)
    • 3.1.2 Global CAR T-Cell Therapy Revenue Market Share by Players (2017-2022)
  • 3.2 Global CAR T-Cell Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Players Covered: Ranking by CAR T-Cell Therapy Revenue
  • 3.4 Global CAR T-Cell Therapy Market Concentration Ratio
    • 3.4.1 Global CAR T-Cell Therapy Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 5 Companies by CAR T-Cell Therapy Revenue in 2021
  • 3.5 CAR T-Cell Therapy Key Players Head office and Area Served
  • 3.6 Key Players CAR T-Cell Therapy Product Solution and Service
  • 3.7 Date of Enter into CAR T-Cell Therapy Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 CAR T-CELL THERAPY BREAKDOWN DATA BY TYPE

  • 4.1 Global CAR T-Cell Therapy Historic Market Size by Type (2017-2022)
  • 4.2 Global CAR T-Cell Therapy Forecasted Market Size by Type (2023-2028)

5 CAR T-CELL THERAPY BREAKDOWN DATA BY APPLICATION

  • 5.1 Global CAR T-Cell Therapy Historic Market Size by Application (2017-2022)
  • 5.2 Global CAR T-Cell Therapy Forecasted Market Size by Application (2023-2028)

6 NORTH AMERICA

  • 6.1 North America CAR T-Cell Therapy Market Size (2017-2028)
  • 6.2 North America CAR T-Cell Therapy Market Size by Type
    • 6.2.1 North America CAR T-Cell Therapy Market Size by Type (2017-2022)
    • 6.2.2 North America CAR T-Cell Therapy Market Size by Type (2023-2028)
    • 6.2.3 North America CAR T-Cell Therapy Market Share by Type (2017-2028)
  • 6.3 North America CAR T-Cell Therapy Market Size by Application
    • 6.3.1 North America CAR T-Cell Therapy Market Size by Application (2017-2022)
    • 6.3.2 North America CAR T-Cell Therapy Market Size by Application (2023-2028)
    • 6.3.3 North America CAR T-Cell Therapy Market Share by Application (2017-2028)
  • 6.4 North America CAR T-Cell Therapy Market Size by Country
    • 6.4.1 North America CAR T-Cell Therapy Market Size by Country (2017-2022)
    • 6.4.2 North America CAR T-Cell Therapy Market Share by Country (2023-2028)
    • 6.4.3 United States
    • 6.4.4 Canada
    • 6.4.5 Mexico

7 EUROPE

  • 7.1 Europe CAR T-Cell Therapy Market Size (2017-2028)
  • 7.2 Europe CAR T-Cell Therapy Market Size by Type
    • 7.2.1 Europe CAR T-Cell Therapy Market Size by Type (2017-2022)
    • 7.2.2 Europe CAR T-Cell Therapy Market Size by Type (2023-2028)
    • 7.2.3 Europe CAR T-Cell Therapy Market Share by Type (2017-2028)
  • 7.3 Europe CAR T-Cell Therapy Market Size by Application
    • 7.3.1 Europe CAR T-Cell Therapy Market Size by Application (2017-2022)
    • 7.3.2 Europe CAR T-Cell Therapy Market Size by Application (2023-2028)
    • 7.3.3 Europe CAR T-Cell Therapy Market Share by Application (2017-2028)
  • 7.4 Europe CAR T-Cell Therapy Market Size by Country
    • 7.4.1 Europe CAR T-Cell Therapy Market Size by Country (2017-2022)
    • 7.4.2 Europe CAR T-Cell Therapy Market Size by Country (2023-2028)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy

8 ASIA-PACIFIC

  • 8.1 Asia-Pacific CAR T-Cell Therapy Market Size (2017-2028)
  • 8.2 Asia-Pacific CAR T-Cell Therapy Market Size by Type
    • 8.2.1 Asia-Pacific CAR T-Cell Therapy Market Size by Type (2017-2022)
    • 8.2.2 Asia-Pacific CAR T-Cell Therapy Market Size by Type (2023-2028)
    • 8.2.3 Asia-Pacific CAR T-Cell Therapy Market Share by Type (2019-2028)
  • 8.3 Asia-Pacific CAR T-Cell Therapy Market Size by Application
    • 8.3.1 Asia-Pacific CAR T-Cell Therapy Market Size by Application (2017-2022)
    • 8.3.2 Asia-Pacific CAR T-Cell Therapy Market Size by Application (2023-2028)
    • 8.3.3 Asia-Pacific CAR T-Cell Therapy Market Share by Application (2019-2028)
  • 8.4 Asia-Pacific CAR T-Cell Therapy Market Size by Region
    • 8.4.1 Asia-Pacific CAR T-Cell Therapy Market Size by Region (2017-2022)
    • 8.4.2 Asia-Pacific CAR T-Cell Therapy Market Size by Region (2023-2028)
    • 8.4.3 China
    • 8.4.4 Japan
    • 8.4.5 South Korea
    • 8.4.6 India

9 SOUTH AMERICA

  • 9.1 South America CAR T-Cell Therapy Market Size (2017-2028)
  • 9.2 South America CAR T-Cell Therapy Market Size by Type
    • 9.2.1 South America CAR T-Cell Therapy Market Size by Type (2017-2022)
    • 9.2.2 South America CAR T-Cell Therapy Market Size by Type (2023-2028)
    • 9.2.3 South America CAR T-Cell Therapy Market Share by Type (2022-2028)
  • 9.3 South America CAR T-Cell Therapy Market Size by Application
    • 9.3.1 South America CAR T-Cell Therapy Market Size by Application (2017-2022)
    • 9.3.2 South America CAR T-Cell Therapy Market Size by Application (2023-2028)
    • 9.3.3 South America CAR T-Cell Therapy Market Share by Application (2022-2028)
  • 9.4 South America CAR T-Cell Therapy Market Size by Country
    • 9.4.1 South America CAR T-Cell Therapy Market Size by Country (2017-2022)
    • 9.4.2 South America CAR T-Cell Therapy Market Size by Country (2023-2028)
    • 9.4.3 Brazil

10 MIDDLE EAST & AFRICA

  • 10.1 Middle East & Africa CAR T-Cell Therapy Market Size (2017-2028)
  • 10.2 Middle East & Africa CAR T-Cell Therapy Market Size by Type
    • 10.2.1 Middle East & Africa CAR T-Cell Therapy Market Size by Type (2017-2022)
    • 10.2.2 Middle East & Africa CAR T-Cell Therapy Market Size by Type (2023-2028)
    • 10.2.3 Middle East & Africa CAR T-Cell Therapy Market Share by Type (2025-2028)
  • 10.3 Middle East & Africa CAR T-Cell Therapy Market Size by Application
    • 10.3.1 Middle East & Africa CAR T-Cell Therapy Market Size by Application (2017-2022)
    • 10.3.2 Middle East & Africa CAR T-Cell Therapy Market Size by Application (2023-2028)
    • 10.3.3 Middle East & Africa CAR T-Cell Therapy Market Share by Application (2025-2028)
  • 10.4 Middle East & Africa CAR T-Cell Therapy Market Size by Country
    • 10.4.1 Middle East & Africa CAR T-Cell Therapy Market Size by Country (2017-2022)
    • 10.4.2 Middle East & Africa CAR T-Cell Therapy Market Size by Country (2023-2028)
    • 10.4.3 Middle East
    • 10.4.4 Africa

11 KEY PLAYERS PROFILES

  • 11.1 Novartis
    • 11.1.1 Novartis Company Details
    • 11.1.2 Novartis Business Overview
    • 11.1.3 Novartis CAR T-Cell Therapy Introduction
    • 11.1.4 Novartis Revenue in CAR T-Cell Therapy Business (2017-2022)
    • 11.1.5 Novartis Recent Development
  • 11.2 Gilead Sciences
    • 11.2.1 Gilead Sciences Company Details
    • 11.2.2 Gilead Sciences Business Overview
    • 11.2.3 Gilead Sciences CAR T-Cell Therapy Introduction
    • 11.2.4 Gilead Sciences Revenue in CAR T-Cell Therapy Business (2017-2022)
    • 11.2.5 Gilead Sciences Recent Development
  • 11.3 Bristol-Myers Squibb
    • 11.3.1 Bristol-Myers Squibb Company Details
    • 11.3.2 Bristol-Myers Squibb Business Overview
    • 11.3.3 Bristol-Myers Squibb CAR T-Cell Therapy Introduction
    • 11.3.4 Bristol-Myers Squibb Revenue in CAR T-Cell Therapy Business (2017-2022)
    • 11.3.5 Bristol-Myers Squibb Recent Development
  • 11.4 J & J
    • 11.4.1 J & J Company Details
    • 11.4.2 J & J Business Overview
    • 11.4.3 J & J CAR T-Cell Therapy Introduction
    • 11.4.4 J & J Revenue in CAR T-Cell Therapy Business (2017-2022)
    • 11.4.5 J & J Recent Development
  • 11.5 JW Therapeutics
    • 11.5.1 JW Therapeutics Company Details
    • 11.5.2 JW Therapeutics Business Overview
    • 11.5.3 JW Therapeutics CAR T-Cell Therapy Introduction
    • 11.5.4 JW Therapeutics Revenue in CAR T-Cell Therapy Business (2017-2022)
    • 11.5.5 JW Therapeutics Recent Development
  • 11.6 FOSUNKite
    • 11.6.1 FOSUNKite Company Details
    • 11.6.2 FOSUNKite Business Overview
    • 11.6.3 FOSUNKite CAR T-Cell Therapy Introduction
    • 11.6.4 FOSUNKite Revenue in CAR T-Cell Therapy Business (2017-2022)
    • 11.6.5 FOSUNKite Recent Development
  • 11.7 CARsgen Therapeutics (Pipeline)
    • 11.7.1 CARsgen Therapeutics Company Details
    • 11.7.2 CARsgen Therapeutics Business Overview
    • 11.7.3 CARsgen Therapeutics CAR T-Cell Therapy Introduction
  • 11.8 Autolus Therapeutics (Pipeline)
    • 11.8.1 Autolus Therapeutics Company Details
    • 11.8.2 Autolus Therapeutics Business Overview
    • 11.8.3 Autolus Therapeutics CAR T-Cell Therapy Introduction
  • 11.9 Sorrento Therapeutics (Pipeline)
    • 11.9.1 Sorrento Therapeutics Company Details
    • 11.9.2 Sorrento Therapeutics Business Overview
    • 11.9.3 Sorrento Therapeutics CAR T-Cell Therapy Introduction
  • 11.10 Mustang Bio (Pipeline)
    • 11.10.1 Mustang Bio Company Details
    • 11.10.2 Mustang Bio Business Overview
    • 11.10.3 Mustang Bio CAR T-Cell Therapy Introduction
  • 11.11 Bluebird Bio (Pipeline)
    • 11.11.1 Bluebird Bio Company Details
    • 11.11.2 Bluebird Bio Business Overview
    • 11.11.3 Bluebird Bio CAR T-Cell Therapy Introduction
    • 11.11.4 Bluebird Bio Recent Development
  • 11.12 Cellectis (Pipeline)
    • 11.12.1 Cellectis Company Details
    • 11.12.2 Cellectis Business Overview
    • 11.12.3 Cellectis CAR T-Cell Therapy Introduction
  • 11.13 Allogene Therapeutics (Pipeline)
    • 11.13.1 Allogene Therapeutics Company Details
    • 11.13.2 Allogene Therapeutics Business Overview
    • 11.13.3 Allogene Therapeutics CAR T-Cell Therapy Introduction
  • 11.14 Celyad (Pipeline)
    • 11.14.1 Celyad Company Details
    • 11.14.2 Celyad Business Overview
    • 11.14.3 Celyad CAR T-Cell Therapy Introduction

12 ANALYST'S VIEWPOINTS/CONCLUSIONS

13 APPENDIX

  • 13.1 Methodology/Research Approach
    • 13.1.1 Research Programs/Design
    • 13.1.2 Market Size Estimation
    • 13.1.3 Market Breakdown and Data Triangulation
  • 13.2 Data Source
    • 13.2.1 Secondary Sources
    • 13.2.2 Primary Sources
  • 13.3 Author List
  • 13.4 Disclaimer